These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7068203)

  • 1. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus.
    Berecek KH; Murray RD; Gross F; Brody MJ
    Hypertension; 1982; 4(1):3-12. PubMed ID: 7061126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a central role for vasopressin in cardiovascular regulation.
    Berecek KH; Webb RL; Brody MJ
    Am J Physiol; 1983 Jun; 244(6):H852-9. PubMed ID: 6859286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an anteroventral third ventricle lesion on NaCl hypertension in Dahl salt-sensitive rats.
    Goto A; Ganguli M; Tobian L; Johnson MA; Iwai J
    Am J Physiol; 1982 Oct; 243(4):H614-8. PubMed ID: 7124969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
    Songu-Mize E; Bealer SL; Caldwell RW
    Hypertension; 1982; 4(5):575-80. PubMed ID: 6286476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.
    Songu-Mize E; Bealer SL; Caldwell RW
    J Hypertens; 1987 Aug; 5(4):461-7. PubMed ID: 3668248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between vasopressin and the anteroventral third ventricle region in deoxycorticosterone/salt hypertension (Brattleboro rat model).
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Ann N Y Acad Sci; 1982; 394():392-7. PubMed ID: 6960771
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
    Intengan HD; Park JB; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):907-13. PubMed ID: 10523383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and deoxycorticosterone hypertension in Brattleboro rats.
    Berecek KH; Brody MJ
    Ann N Y Acad Sci; 1982; 394():319-29. PubMed ID: 6960766
    [No Abstract]   [Full Text] [Related]  

  • 14. Lesions of the AV3V region attenuate sympathetic activation but not the hypertension elicited by destruction of the nucleus tractus solitarius.
    Catelli JM; Sved AF
    Brain Res; 1988 Jan; 439(1-2):330-6. PubMed ID: 3359192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anteroventral third ventricle lesions on vasopressin release by organ-cultured hypothalamo-neurohypophyseal explants.
    Sladek CD; Johnson AK
    Neuroendocrinology; 1983 Jul; 37(1):78-84. PubMed ID: 6888661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of DOCA-salt hypertension in the Brattleboro rat.
    Saito T; Yajima Y
    Ann N Y Acad Sci; 1982; 394():309-18. PubMed ID: 6960765
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced cAMP response to vasopressin in the CCT of DOCA-Na hypertensive rats.
    Pettinger WA; Fallet R; Wang Y; Tam LT; Jeffries WB
    Am J Physiol; 1986 Dec; 251(6 Pt 2):F1096-100. PubMed ID: 3024505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorthalidone reduces vascular hyperresponsiveness in DOCA-salt hypertensive rats.
    Cabral AM; Musso MN; Bissoli NS; Carvalhinho FB; Vasquez EC
    Clin Exp Hypertens A; 1992; 14(4):667-83. PubMed ID: 1628412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.